Abstract
Get full access to this article
View all access options for this article.
References
1.
Cohen
JA
Chun
J
. Mechanisms of fingolimod’s efficacy and adverse effects in multiple sclerosis . Ann Neurol 2011 ; 69 : 759 –777 .
2.
Jain
N
Bhatti
MT
. Fingolimod-associated macular edema: Incidence, detection and management . Neurology 2012 ; 78 : 672 –680
3.
Afshar
AR
Fernandes
JK
Patel
RD
. Cystoid macular edema associated with fingolimod use for multiple sclerosis . JAMA Ophthalmol 2013 ; 131 : 103 –107 .
4.
Bhatti
MT
Freedman
SM
Mahmoud
TH
. Fingolimod therapy and macular hemorrhage . J Neuroophthalmol 2013 ; 33 : 370 –372 .
5.
Kappos
L
Antel
J
Comi
G
. Oral fingolimod (FTY720) for relapsing multiple sclerosis . N Engl J Med 2006 ; 355 : 1124 –1140 .